WIM
ALNY icon

Westside Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Westside Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Hold
96
– – ﹤0.01% 793
2026
Q1 		$30.6K Hold
96
– – ﹤0.01% 730
2025
Q4 		$38.4K Hold
96
– – 0.01% 628
2025
Q3 		$44.2K Buy
96
+48
+100% +$19.5K 0.01% 580
2025
Q2 		$15.5K Buy
+48
New +$13.3K ﹤0.01% 780

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westside Investment Management's ALNY Position: Q2 2026 in Review

Westside Investment Management held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 96 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Westside Investment Management first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $44.2K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Westside Investment Management held 96 shares of Alnylam Pharmaceuticals worth $28.9K as of Q2 2026.
  • Westside Investment Management left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #793 holding.
  • Westside Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Westside Investment Management's Alnylam Pharmaceuticals position peaked at $44.2K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.